Fumi Goshima Selected Research

Fumi Goshima Research Topics

Disease

19	Infections 01/2017 - 02/2001
17	Neoplasms (Cancer) 03/2021 - 07/2003
6	Lymphoma (Lymphomas) 11/2016 - 01/2013
3	Epstein-Barr Virus Infections 11/2018 - 01/2011
3	Melanoma (Melanoma, Malignant) 01/2017 - 06/2008
3	Latent Infection 09/2015 - 04/2002
3	Ovarian Neoplasms (Ovarian Cancer) 06/2014 - 10/2003
2	Nasopharyngeal Carcinoma 06/2017 - 04/2016
2	Urinary Bladder Neoplasms (Bladder Cancer) 02/2010 - 11/2005
2	Breast Neoplasms (Breast Cancer) 08/2006 - 01/2004
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2020
1	Stomach Neoplasms (Stomach Cancer) 06/2017
1	B-Cell Lymphoma (Lymphoma, B Cell) 06/2017
1	Carcinogenesis 04/2016
1	Herpes Simplex 09/2013
1	Colorectal Neoplasms (Colorectal Cancer) 04/2013
1	Herpes Genitalis (Genital Herpes) 01/2012
1	Insulinoma 05/2011
1	Brain Neoplasms (Brain Tumor) 06/2008
1	Inflammation (Inflammations) 01/2008
1	Squamous Cell Carcinoma of Head and Neck 10/2006
1	Herpes Simplex Encephalitis (Herpes Encephalitis) 09/2005
1	Neurodegenerative Diseases (Neurodegenerative Disease) 05/2005
1	Virus Diseases (Viral Diseases) 09/2003
1	Encephalitis (Encephalitis, Rasmussen) 09/2003
1	Astrocytoma (Pilocytic Astrocytoma) 04/2002

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 06/2017 - 02/2001
4	Membrane Proteins (Integral Membrane Proteins)IBA 06/2017 - 01/2013
2	CytokinesIBA 01/2020 - 04/2002
2	Monoclonal AntibodiesIBA 01/2017 - 05/2004
2	Pharmaceutical PreparationsIBA 01/2015 - 02/2010
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2015 - 01/2013
2	AntigensIBA 01/2012 - 09/2003
2	Paclitaxel (Taxol)FDA LinkGeneric 02/2010 - 10/2003
2	Protein Kinases (Protein Kinase)IBA 06/2006 - 09/2003
1	Interleukin-2 (IL2)IBA 01/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020
1	Interleukin-12 (IL 12)IBA 01/2020
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2020
1	Green Fluorescent ProteinsIBA 01/2020
1	alsterpaulloneIBA 01/2020
1	Histones (Histone)IBA 11/2018
1	Enhancer of Zeste Homolog 2 ProteinIBA 11/2018
1	MethyltransferasesIBA 11/2018
1	Lysine (L-Lysine)FDA Link 11/2018
1	Dacarbazine (DIC)FDA LinkGeneric 01/2017
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2017
1	Cytotoxins (Cytolysins)IBA 01/2017
1	Serine (L-Serine)FDA Link 01/2017
1	Alanine (L-Alanine)FDA Link 01/2017
1	tofacitinibIBA 11/2016
1	Viral DNAIBA 09/2015
1	6- chloro- 9- (4- methoxy- 3,5- dimethylpyridin- 2- ylmethyl)- 9H- purin- 2- ylamineIBA 01/2015
1	mogamulizumabIBA 10/2014
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 06/2014
1	Vorinostat FDA Link 06/2014
1	Histone Deacetylases (Histone Deacetylase)IBA 06/2014
1	Histone Deacetylase InhibitorsIBA 06/2014
1	Interleukin-6 (Interleukin 6)IBA 09/2013
1	Gemcitabine FDA Link 04/2013
1	monorden (radicicol)IBA 01/2013
1	tanespimycin (17AAG)IBA 01/2013
1	Oncogene Proteins (Oncogene Protein)IBA 01/2013
1	InterferonsIBA 01/2012
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2012
1	TankyrasesIBA 01/2012
1	VaccinesIBA 01/2012
1	Transcription Factors (Transcription Factor)IBA 05/2011
1	Small Interfering RNA (siRNA)IBA 05/2011
1	Antiviral Agents (Antivirals)IBA 01/2011
1	enhanced green fluorescent proteinIBA 01/2011
1	DNA (Deoxyribonucleic Acid)IBA 01/2011
1	ProdrugsIBA 02/2010
1	paclitaxel 2'-ethylcarbonateIBA 02/2010
1	EnzymesIBA 02/2010
1	Fas Ligand Protein (Fas Ligand)IBA 11/2009
1	Interferon-gamma (Interferon, gamma)IBA 11/2009
1	Viral AntigensIBA 06/2008
1	Messenger RNA (mRNA)IBA 04/2008
1	Interleukin-15 (Interleukin 15)IBA 01/2008
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2008
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 01/2008
1	Connexin 43 (Connexin43)IBA 10/2007
1	Amyloid beta-PeptidesIBA 09/2005
1	Antineoplastic Agents (Antineoplastics)IBA 04/2004
1	5-bromo-4-chloro-3-indolyl beta-galactoside (X-gal)IBA 10/2003
1	JNK Mitogen-Activated Protein KinasesIBA 09/2003
1	Biological ProductsIBA 09/2003
1	p38 Mitogen-Activated Protein KinasesIBA 09/2003
1	E-SelectinIBA 09/2003
1	HLA-DR Antigens (HLA-DR)IBA 09/2003
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 09/2003
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 09/2003
1	Acyclovir (Aciclovir)FDA LinkGeneric 06/2002

Therapy/Procedure

14	Therapeutics 01/2018 - 07/2003
6	Oncolytic Virotherapy 03/2021 - 06/2007
3	Drug Therapy (Chemotherapy) 01/2017 - 01/2015
2	Intraperitoneal Injections 04/2013 - 06/2008